Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Nagasaka

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Translational Vision Science & Technology|March 11, 2022
The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic SurgeonsPeirong Huang, Siddharth Narendran, Felipe Pereira, et al.
Scientific Reports|January 10, 2015
Plasma-activated medium suppresses choroidal neovascularization in mice: a new therapeutic concept for age-related macular degenerationFuxiang Ye, Hiroki Kaneko, Yosuke Nagasaka, et al.
Investigative Ophthalmology & Visual Science|January 24, 2017
Role of Caveolin-1 for Blocking the Epithelial-Mesenchymal Transition in Proliferative VitreoretinopathyYosuke Nagasaka, Hiroki Kaneko, Fuxiang Ye, et al.
Angiogenesis|September 24, 2024
Inflammasome activation aggravates choroidal neovascularizationRyan D Makin, Ivana Apicella, Roshni Dholkawala, et al.
Biomed Research International|March 7, 2017
Correlation between miR-148 Expression in Vitreous and Severity of Rhegmatogenous Retinal DetachmentTaichi Tsunekawa, Hiroki Kaneko, Kei Takayama, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Reduction of human Alzheimer's disease risk and reversal of mouse model cognitive deficit with nucleoside analog useJoseph Magagnoli, Praveen Yerramothu, Kameshwari Ambati, et al.
Investigative Ophthalmology & Visual Science|May 2, 2023
Kamuvudine-9 Protects Retinal Structure and Function in a Novel Model of Experimental Rhegmatogenous Retinal DetachmentPeirong Huang, Claire C Thomas, Kameshwari Ambati, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2021
Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degenerationMeenakshi Ambati, Ivana Apicella, Shao-Bin Wang, et al.
Signal Transduction and Targeted Therapy|April 14, 2021
Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degenerationSiddharth Narendran, Felipe Pereira, Praveen Yerramothu, et al.
Nature Metabolism|February 2, 2023
Phagocytosis in the retina promotes local insulin production in the eyeJ Iker Etchegaray, Shannon Kelley, Kristen Penberthy, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Translational Vision Science & Technology|March 11, 2022
The Learning Curve of Murine Subretinal Injection Among Clinically Trained Ophthalmic SurgeonsPeirong Huang, Siddharth Narendran, Felipe Pereira, et al.
Scientific Reports|January 10, 2015
Plasma-activated medium suppresses choroidal neovascularization in mice: a new therapeutic concept for age-related macular degenerationFuxiang Ye, Hiroki Kaneko, Yosuke Nagasaka, et al.
Investigative Ophthalmology & Visual Science|January 24, 2017
Role of Caveolin-1 for Blocking the Epithelial-Mesenchymal Transition in Proliferative VitreoretinopathyYosuke Nagasaka, Hiroki Kaneko, Fuxiang Ye, et al.
Angiogenesis|September 24, 2024
Inflammasome activation aggravates choroidal neovascularizationRyan D Makin, Ivana Apicella, Roshni Dholkawala, et al.
Biomed Research International|March 7, 2017
Correlation between miR-148 Expression in Vitreous and Severity of Rhegmatogenous Retinal DetachmentTaichi Tsunekawa, Hiroki Kaneko, Kei Takayama, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Reduction of human Alzheimer's disease risk and reversal of mouse model cognitive deficit with nucleoside analog useJoseph Magagnoli, Praveen Yerramothu, Kameshwari Ambati, et al.
Investigative Ophthalmology & Visual Science|May 2, 2023
Kamuvudine-9 Protects Retinal Structure and Function in a Novel Model of Experimental Rhegmatogenous Retinal DetachmentPeirong Huang, Claire C Thomas, Kameshwari Ambati, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2021
Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degenerationMeenakshi Ambati, Ivana Apicella, Shao-Bin Wang, et al.
Signal Transduction and Targeted Therapy|April 14, 2021
Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degenerationSiddharth Narendran, Felipe Pereira, Praveen Yerramothu, et al.
Nature Metabolism|February 2, 2023
Phagocytosis in the retina promotes local insulin production in the eyeJ Iker Etchegaray, Shannon Kelley, Kristen Penberthy, et al.
Pageof 4